Delivery Order SPE2DB20D9331-SPE2DB23FL0V6
- Not listed
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $63,801.78, is for the delivery of 4,568,202,064 units of Perjeta 420 mg/14 ml vial. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at $499,999,999 and valid through November 2026. The IDC enables the DLA...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract award, valued at $12,415.50, is for the delivery of Perjeta, a 420 mg/14 ml vial medication, with an ultimate completion date of April 13, 2023. This delivery order is placed under DMS Pharmaceutical Group's $499,999,999 Indefinite Delivery Contract (IDC) with the DLA, which...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $33,108 contract is for the delivery of 420 mg/14 ml vials of the drug Perjeta, with a completion date of October 3, 2023. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which...
- This is a firm fixed price delivery order issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order is for the supply of Perjeta 420 mg/14 mL vials and has a ceiling value of $41,385.00. The order falls under a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA, which allows the agency to issue orders for a...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $8,509.92 contract is for the delivery of 420 mg/14 ml vials of the cancer drug Perjeta. This delivery order is part of a larger single-award indefinite delivery contract (IDC) valued up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. This IDC...
- This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $25,529.76 contract is for the delivery of Perjeta, a 420 mg/14 ml vial oncology medication, with a period of performance through April 9, 2024. This delivery order is placed against DMS Pharmaceutical Group's existing indefinite delivery vehicle (IDV) contract SPE2DB, a single-award contract valued up to...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $38,294.64, is for the delivery of Perjeta 420 mg/14 ml vials with a completion date of June 4, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. The IDC...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The order, valued at $4,254.96, is for the supply of 420 mg/14 ml vials of the prescription drug Perjeta. The delivery order is part of a larger indefinite delivery vehicle (IDV) contract, SPE2DB, held by DMS Pharmaceutical Group with the DLA, valued at up to $4,999,999 through 2025. This IDV enables the DLA to issue firm fixed-price...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth up to $25,529.76 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of 4563969889 - Perjeta 420 mg/14 ml vial, 14 ml, with a performance period through April 1, 2024. This delivery order is issued under DMS Pharmaceutical Group's indefinite delivery contract SPE2DB24FSW68 with DLA, which has a ceiling value of up to...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $34,039.68, is for the delivery of Perjeta 420 mg/14 ml vial, a branded oncology medication, with a performance period ending on July 3, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS...
- SPE2DB20D9331Indefinite Delivery Contract
- SPE2DB20D9331-SPE2DB23FL0V6Delivery Order
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $82,770.00 contract is for the supply of 4,560,409,012 units of Perjeta 420 mg/14 ml vial. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) under the SPE2DB program, which allows the DLA to issue fixed-price orders for a comprehensive range of pharmaceutical items to support the medical supply needs of Department of Defense (DoD) healthcare facilities worldwide. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, providing a wide variety of medications, biologics, and medical consumables to the DoD and Department of Veterans Affairs. This specific delivery order has no set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $82.8k | 3/23/23 |